Page last updated: 2024-10-28

hexamethylene bisacetamide and Obesity

hexamethylene bisacetamide has been researched along with Obesity in 1 studies

N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Park, S1
Oh, S1
Kim, N1
Kim, EK1

Other Studies

1 other study available for hexamethylene bisacetamide and Obesity

ArticleYear
HMBA ameliorates obesity by MYH9- and ACTG1-dependent regulation of hypothalamic neuropeptides.
    EMBO molecular medicine, 2023, Dec-07, Volume: 15, Issue:12

    Topics: Acetamides; Animals; Mice; Obesity; Pro-Opiomelanocortin; Transcription Factors; Tumor Suppressor Pr

2023